This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Substantia Innominata : Atrophy, Gait Variability and Dual-Task Gait Across the Lewy Body Disease Spectrum.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2026
Life-course trajectories and modifiable risk factors for incident walking limitation and mortality in 25 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
The Lancet. Healthy Longevity · 2026
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
The journal of prevention of Alzheimer's disease · 2025
Latest funding
- $120,000
Blood transfusion as a risk factor for lobar intracerebral hemorrhage
CIHR · 2026 · Co-investigator
- $140,000
Plasma Biomarkers and Proteomic Signatures of Cerebral Amyloid Angiopathy: Disentangling CAA and Alzheimer's Disease Along the Amyloid Spectrum
CIHR · 2025 · Supervisor
- $680,850
MRI-to-Biomarker Image Translation for Alzheimer's Disease: Externally Validated MRI-derived Amyloid-Beta (Centiloid) and Tau Estimates
CIHR · 2025 · Co-investigator
20 publications.
Substantia Innominata : Atrophy, Gait Variability and Dual-Task Gait Across the Lewy Body Disease Spectrum.
Yeung AK, Gee M, Ba F, Almeida Q, Smith E, Nelles K, Sharma B, Masellis M, Black S, Pieruccini-Faria F, Montero-Odasso M, Camicioli R
Life-course trajectories and modifiable risk factors for incident walking limitation and mortality in 25 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Joundi RA, Rangarajan S, Bangdiwala S, Leong D, Smith E, Miller V, Bosch J, Ismail R, Alhabib KF, Rosengren A
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
Macfarlane S, Grimmer T, Teo K, O'Brien TJ, Woodward M, Grunfeld J, Mander A, Brodtmann A, Brew BJ, Morris P, Short C, Kurrle S, Lai R, Bharadwaj S, Drysdale P, Sturm J, Lewis SJG, Barton D, Kalafatis C, Sharif S, Perry R, Mannering N, MacSweeney JE, Pearson S, Evans C, Krishna V, Thompson A, Munisamy M, Bhatt N, Asher A, Connell S, Lynch J, Rutgers SM, Dautzenberg PL, Prins N, Oschmann P, Frölich L, Tacik P, Peters O, Wiltfang J, Henri-Bhargava A, Smith E, Pasternak S, Frank A, Chertkow H, Ingram J, Hsiung GR, Brittain R, Tartaglia C, Cohen S, Villa LM, Gordon E, Jubault T, Guizard N, Tucker A, Kaufmann WE, Jin K, Chezem WR, Missling CU, Sabbagh MN
Risk factors for 30-day COVID-19 mortality among people living with dementia in Alberta, Canada: a retrospective cohort study.
Goerzen M, Gruneir A, Cetin-Sahin D, Godard-Sebillotte C, Smith E, Roach P, Kirkham J, Seitz D
Association of dietary macronutrients with MRI-detected vascular brain injury and cognition in 9886 middle-aged participants from four countries: for the Canadian Alliance of Healthy Hearts and Minds (CAHHM) and the Prospective Urban Rural Epidemiological (PURE) Study Investigators
Miller V, Smith E, Schulze KM, Desai D, Ho V, Dummer TJB, Tardif J-C, Lear S, Poirier P, Mir H
Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
Naude J, Wang M, Leon R, Smith E, Ismail Z
Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
Naude J, Wang M, Leon R, Smith E, Ismail Z
Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)
Chertkow H, Phillips N, Rockwood K, Anderson N, Andrew MK, Bartha R, Beaudoin C, Bélanger N, Bellec P, Belleville S
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis.
Martí-Fàbregas J, Camps-Renom P, Best JG, Ramos-Pachon A, Guasch-Jiménez M, Martinez-Domeño A, Guisado-Alonso D, Gómez-Ansón BM, Ambler G, Wilson D, Lee KJ, Lim JS, Bae HJ, Shiozawa M, Koga M, Toyoda K, Hennerici MG, Chabriat H, Jouvent E, Wong DYK, Mak H, Lau KK, Kim YD, Song TJ, Heo JH, Eppinger S, Gattringer T, Uysal E, Demirelli DS, Bornstein N, Ben Assayag E, Hallevi H, Molad JA, Nishihara M, Tanaka J, Hara H, Yakushiji Y, Coutts SB, Smith E, Polymeris AA, Wagner B, Seiffge D, Lyrer PA, Peters N, Engelter ST, Al-Shahi Salman R, Jäger HR, Lip GYH, Goeldlin M, Panos L, Karayiannis CC, Phan TG, Srikanth VK, Christ N, Gunkel S, Fluri F, Leung TW, Soo YOY, Chu W, Abrigo J, Barbato C, Browning S, Simister R, Mendyk AM, Bordet R, Hilal S, Gyanwali B, Chen C, Jung S, Necioglu Orken D, Werring D, Prats-Sanchez L, Microbleeds International Collaborative Network (MICON)
Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
Ghahremani M, Wang M, Chen HY, Zetterberg H, Smith E, Ismail Z, Alzheimer's Disease Neuroimaging Initiative*
Blood transfusion as a risk factor for lobar intracerebral hemorrhage
Principal investigators: Hill, Michael D; Arnold, Donald M
Keywords: Blood Transfusion; Cerebral Amyloid Angiopathy; Clinical Epidemiology; Intracerebral Hemorrhage
Plasma Biomarkers and Proteomic Signatures of Cerebral Amyloid Angiopathy: Disentangling CAA and Alzheimer's Disease Along the Amyloid Spectrum
Principal investigators: Dallaire-Théroux, Caroline
Keywords: Aging; Alzheimer'S Disease; Blood-Based Biomarkers; Cerebral Amyloid Angiopathy; Cognitive Impairment; Dementia; Diagnosis; Magnetic Resonance Imaging (Mri); Neuroimaging; Proteomics
MRI-to-Biomarker Image Translation for Alzheimer's Disease: Externally Validated MRI-derived Amyloid-Beta (Centiloid) and Tau Estimates
Principal investigators: MacDonald, Ethan
Keywords: Aging; Alzheimer'S Disease; Amyloid And Tau Protein; Magnetic Resonance Imaging; Positron Emission Tomography
Innovating Driving Assessment in Adults with Cognitive Impairment: A Person-Centered Approach Leveraging Artificial Intelligence and Digital Technology
Principal investigators: Bayat, Sayeh; Naglie, Gary; Rapoport, Mark J
Keywords: Artificial Intelligence; Automobile Driving; Cognitive Impairment; Dementia; Digital Technology; Driving Safety; Mobility; Older Adults
Biomarkers and Mild Behavioural Impairment (BAMBI) - Sample Enrichment for Alzheimer Disease Biomarker Positivity
Principal investigators: Ismail, Zahinoor
Keywords: Alzheimer Disease; Amyloid; Biomarkers; Early Detection; Mild Behavioural Impairment; Mild Cognitive Impairment; Observational Cohort; Subjective Cognitive Decline; Tau
ABACUS: Advanced Brain Frailty and Cognitive Sequelae of Stroke
Principal investigators: Ganesh, Aravind; Barber, Philip A; Goyal, Mayank; Hill, Michael D; Swartz, Richard
Keywords: Atrophy; Brain Frailty; Chronic Infarcts; Cognitive Impairment; Cognitive Outcomes; Neuroimaging; Silent Brain Infarcts; Stroke; Transient Ischemic Attack; White Matter Disease
Aging with neurodiversity: Investigating allostatic and vascular health as modifiable factors impacting brain aging in older adults with ADHD
Principal investigators: Callahan, Brandy L
Keywords: Adhd; Allostatic Health; Modifiable Health Factors; Neurodivergence; Neurodiversity; Vascular Health
LIFE (Lifestyle Interventions to Fend off dEmentia): A Systematic Review and Network Meta-Analysis of Lifestyle Interventions to Prevent Dementia.
Principal investigators: Goodarzi, Zahra S; Holroyd-Leduc, Jayna M; Seitz, Dallas P; Watt, Jennifer A
Keywords: Cognitive Impairment; Dementia; Diet; Exercise; Lifestyle Interventions; Network Meta Analysis; Policy; Prevention; Risk Reduction; Systematic Review
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
Principal investigators: Menon, Bijoy K; Christenson, James M; Hill, Michael D; Singh, Nishita; Swartz, Richard; Tymianski, Michael
Keywords: Acute; Neuro-Protection; Stroke; Thrombolysis
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
Principal investigators: Menon, Bijoy K; Christenson, James M; Hill, Michael D; Singh, Nishita; Swartz, Richard; Tymianski, Michael
Keywords: Acute; Neuro-Protection; Stroke; Thrombolysis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Medicine/Cardiology
- Clinical Neurosciences
- Geriatric Medicine
- Psychiatry
- Internal Medicine
- Nursing
- Other
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Zahinoor Ismail
Psychiatry
3 shared papers, latest 2024
Eric Smith
Geriatric Medicine
3 shared papers, latest 2023
Darlene Kitty
Internal Medicine
2 shared papers, latest 2023
Jacob Udell
Medicine/Cardiology
2 shared papers, latest 2023
Diana Sherifali
Medicine
2 shared papers, latest 2023
Mario Masellis
Medicine
2 shared papers, latest 2026
Jacob Udell
Nephrology
2 shared papers, latest 2023
Diana Sherifali
Faculty
2 shared papers, latest 2023
Howard Chertkow
Medicine
2 shared papers, latest 2025
Howard Chertkow
Psychology
2 shared papers, latest 2025
Eric Smith
Medicine
2 shared papers, latest 2023
Manuel Montero Odasso
Department of Epidemiology and Biostatistics
2 shared papers, latest 2026
Laurent Macle
Faculty
2 shared papers, latest 2023
Kara Nerenberg
Medicine
2 shared papers, latest 2023
Eric Smith
Faculty
2 shared papers, latest 2023
Peter Selby
Department of Family and Community Medicine
2 shared papers, latest 2023
Kara Nerenberg
Medicine
2 shared papers, latest 2023
Dallas Seitz
Medicine
2 shared papers, latest 2025
Peter Selby
Faculty
2 shared papers, latest 2023
Pamela Roach
Community Health Sciences
2 shared papers, latest 2025
Diana Sherifali
Nursing
2 shared papers, latest 2023
Raed Joundi
Medicine
2 shared papers, latest 2026
Sean Wharton
Medicine
2 shared papers, latest 2023
Gina Agarwal
Faculty
2 shared papers, latest 2023
Gina (Ragini) Agarwal
Family Medicine
2 shared papers, latest 2023
George Thanassoulis
Medicine/Cardiology
2 shared papers, latest 2023
Salim Yusuf
Medicine
2 shared papers, latest 2026
Karen Tu
Family and Community Medicine
2 shared papers, latest 2023
Sandra Black
Medicine
2 shared papers, latest 2026
Nicole Anderson
Medicine
1 shared papers, latest 2024
Edward Fon
Neurology and Neurosurgery
1 shared papers, latest 2024
Bojana Stefanovic
Department of Medical Biophysics
1 shared papers, latest 2024
Shrikant Bangdiwala
Health Research Methods, Evidence, and Impact
1 shared papers, latest 2026
Alex Mihailidis
Department of Occupational Science and Occupational Therapy
1 shared papers, latest 2024
Neil Cashman
UBC James Hogg Research Centre
1 shared papers, latest 2024
Debra Morgan
Medicine
1 shared papers, latest 2024
Howard Bergman
Family Medicine
1 shared papers, latest 2024
Scott Lear
Faculty
1 shared papers, latest 2025
Nathan Herrmann
Psychiatry
1 shared papers, latest 2024
Peter ST GEORGE-HYSLOP
Medicine
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.